Irritable Bowel Syndrome: all 1,084 studies

Page 9 of 11. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.

• A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide TherapeuticallyCompletedNCT02220348Phase 1
• Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel SyndromeCompletedNCT02213172Phase 2
• Probiotics in Intestinal Bacterial OvergrowthCompletedNCT02204891Not applicable
• Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBDCompletedNCT02197780
• Effects of Mesalamine and Amitriptyline on Irritable Bowel SyndromeWithdrawnNCT02190526Phase 4
• Irritable Bowel Syndrome and Low FODMAP DietCompletedNCT02188680Not applicable
• Irritable Bowel Syndrome and Food SensitivityCompletedNCT02186743Not applicable
• Brain Imaging, Heart Rate Variability and Serum Fatty Acid in Subjects With Irritable Bowel SyndromeCompletedNCT02179905
• A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel SyndromeStatus unknownNCT02179580Phase 2/3
• Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-DCompletedNCT02163213Not applicable
• Effect of Two Different Rye Bread Types in Irritable Bowel SyndromeCompletedNCT02161120Not applicable
• Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial.CompletedNCT02154867Phase 2
• Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)TerminatedNCT02144753Phase 2
• Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBDCompletedNCT02136745Not applicable
• Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal DisordersCompletedNCT02113605Not applicable
• Effects of Fasting on Self EfficacyCompletedNCT02113111
• The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel SyndromeCompletedNCT02108119Phase 2
• Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS PatientsCompletedNCT02107625Not applicable
• Fecal Microbiota Transplantation in Patients With Irritable Bowel SyndromeCompletedNCT02092402Not applicable
• Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With ConstipationCompletedNCT02082457Phase 2
• Symptom Management for Irritable Bowel SyndromeCompletedNCT02079857Not applicable
• Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel SyndromeCompletedNCT02079675Phase 2
• Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C PatientsCompletedNCT02078323Not applicable
• Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical StudyCompletedNCT02077699Phase 4
• A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel SyndromeCompletedNCT02074579Phase 2
• Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and MicrobiotaStatus unknownNCT02040922
• Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot StudyCompletedNCT02033161Not applicable
• Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel SyndromeCompletedNCT02026518Phase 4
• The Effects of Rifaximin Therapy in Irritable Bowel SyndromeCompletedNCT02009618Not applicable
• Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in KoreaCompletedNCT02003807
• Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal DiseaseWithdrawnNCT01966341Not applicable
• Multimodal Stimulation Before and After Sacral Nerve Stimulation for Irritable Bowel SyndromeCompletedNCT01950715Not applicable
• Subsensory Sacral Nerve Stimulation for Irritable Bowel SyndromeCompletedNCT01948973Not applicable
• Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to PlaceboCompletedNCT01940848Phase 3
• Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome PatientsWithdrawnNCT01916200Phase 4
• Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter TrialCompletedNCT01908465Phase 4
• A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT01896583Phase 2
• Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D TreatmentStatus unknownNCT01893606Phase 2/3
• Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)CompletedNCT01890837Phase 1/2
• Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel SyndromeCompletedNCT01887834Phase 1/2
• Vetal Laban Intervention Trial Assessing Bowel SymptomsTerminatedNCT01887483Phase 4
• Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)TerminatedNCT01887002Phase 2
• Stress Management for Irritable Bowel SyndromeCompletedNCT01886027Not applicable
• A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)CompletedNCT01870895Phase 3
• Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)CompletedNCT01855711Phase 2
• Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.CompletedNCT01854060
• A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT01844180Phase 2
• Probiotics in the Treatment of Irritable Bowel SyndromeCompletedNCT01837485Phase 2/3
• Probiotics in the Treatment of Irritable Bowel SyndromeCompletedNCT01837472Phase 2/3
• The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome StudyCompletedNCT01829932Not applicable
• Effect of Hypnotherapy and Educational Intervention in Irritable Bowel SyndromeCompletedNCT01815164Not applicable
• Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel SyndromeStatus unknownNCT01803724
• Repetitive Transcranial Magnetic Stimulation in Irritable Bowel SyndromeCompletedNCT01801605Phase 2
• The Diagnostic Predictability of Food Allergy TestingCompletedNCT01791621Not applicable
• Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)CompletedNCT01787253
• The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)Status unknownNCT01779765Phase 4
• Fructose and Fructans in Irritabla Bowel SyndromeCompletedNCT01776853Not applicable
• IQP-CL-101 in IBS ManagementCompletedNCT01774825Phase 3
• Physical Activity in IBS - a Long Term Follow upCompletedNCT01774695Not applicable
• A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT01736423Phase 3
• Evaluating and Treating Potential Research Participants With Digestive DisordersTerminatedNCT01736280Not applicable
• Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal SymptomsCompletedNCT01728610Phase 2
• Spinal Cord Stimulation for Pain Relief in Irritable Bowel SyndromeCompletedNCT01726751Phase 1/2
• 25-hydroxyvitamin D and Fatigue: The VITALITY StudyCompletedNCT01718925
• A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel SyndromeCompletedNCT01714843Phase 2
• Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?CompletedNCT01705171
• Mesalazine Treatment in IBS (The MIBS Study)CompletedNCT01699438Phase 2
• Probiotics for the Treatment of Irritable Bowel Syndrome in Celiac PatientsStatus unknownNCT01699191Not applicable
• Effect of Milk-free Diet on Weight and Irritable Bowel Syndrome in Morbid ObesityWithdrawnNCT01686919Not applicable
• Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium BromideCompletedNCT01678781
• Sucrose Breath Test to Determine Intestinal Permeability in IBSCompletedNCT01674088
• Irritable Bowel Syndrome Evaluation and Treatment in Primary CareCompletedNCT01641341Phase 4
• A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel SyndromeStatus unknownNCT01641224Not applicable
• Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-DStatus unknownNCT01638208Phase 4
• The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel SyndromeStatus unknownNCT01637714Not applicable
• Phase I Clinical Trial of DA-6886 in Healthy Male SubjectsCompletedNCT01633723Phase 1
• Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel SyndromeStatus unknownNCT01632488
• Effects of an Integrative Treatment Model to Reduce Anxiety and Depression in Minor Mental Health Problems and Medically Unexplained SymptomsCompletedNCT01631500Not applicable
• Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel SyndromeStatus unknownNCT01629212Phase 4
• Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel SyndromeCompletedNCT01624610Not applicable
• Mode of Action of MoviprepCompletedNCT01622972Phase 4
• Mindfulness-Based Stress Reduction and the MicrobiomeCompletedNCT01619384Not applicable
• Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic SacrocolpopexyCompletedNCT01618292
• Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel SyndromeCompletedNCT01613456Not applicable
• Neuroimaging and Biomarkers in Chronic Visceral PainCompletedNCT01602575Not applicable
• Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel SyndromeCompletedNCT01574209
• The Effect of Neu-P11 on Symptoms in Patients With D-IBSCompletedNCT01558284
• Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic DisorderCompletedNCT01551225Phase 4
• Effect of BIO-K+ on Symptoms of Irritable Bowel SyndromeCompletedNCT01545037Phase 2
• Effect of Pentoxifylline on Tight Junctions (TJs) of Intestinal Mucosa in Patients With Irritable Bowel Syndrome(IBS)Status unknownNCT01542268Phase 4
• Small and Large Bowel Transit Tests Using MRI (Study 1)CompletedNCT01534507
• Cognitive Behavioral Therapy With Our Without Exposure Therapy for Irritable Bowel SyndromeCompletedNCT01529567Not applicable
• Irritable Bowel Syndrome and Lactibiane ToleranceCompletedNCT01529359Not applicable
• Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest.CompletedNCT01517516
• Comparative Efficacy and Safety of FenoverineCompletedNCT01507922Phase 4
• Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant DiarrheaCompletedNCT01505777Phase 2
• Post-Infectious Irritable Bowel Syndrome (PI-IBS)CompletedNCT01497847
• Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in ChildhoodCompletedNCT01495806Phase 4
• A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel SyndromeCompletedNCT01494233Phase 2
• The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS)CompletedNCT01483287Early Phase 1

← Irritable Bowel Syndrome overview